Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
miriam.lichtner@uniroma1.it
Miriam Lichtner
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
miriam.lichtner@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Spontaneous pneumomediastinum as the only CT finding in an asymptomatic adolescent positive for COVID-19
BJR CASE REPORTS
2020
Impact of ifn-free and ifn-based treatment on blood myeloid dendritic cell, monocyte, slan-dc, and activated t lymphocyte dynamics during hcv infection
JOURNAL OF IMMUNOLOGY RESEARCH
2020
Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
2019
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014
HIV MEDICINE
2019
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy
SEXUALLY TRANSMITTED INFECTIONS
2019
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice. Evidence of a relevant risk of death and evolution from silent to chronic infection
JOURNAL OF VIRAL HEPATITIS
2019
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
2019
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
BMC PUBLIC HEALTH
2019
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition
JOURNAL OF NEUROCHEMISTRY
2018
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus
BIOMED RESEARCH INTERNATIONAL
2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
2018
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
PLOS ONE
2018
Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs)
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
2018
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals. An observational cohort study
BMC MEDICINE
2018
Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report
MEDICINE
2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison
HIV MEDICINE
2018
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy
BMC PUBLIC HEALTH
2018
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets
VIRUSES
2018
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
BMC INFECTIOUS DISEASES
2018
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters
IMMUNOBIOLOGY
2018
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
Progetti di Ricerca
Marcatori di risposta e modificazioni del pattern infiammatorio in una corte di pazienti con polmonite da SARS-Cov2 sottoposti al trattamento con farmaci immunomodulanti
Ruolo dell'immunità innata nell'infezione da SARS-COV2 in una corte di pazienti con polmonite da COVID: biomarkers e correlati clinici
Risposta immune innata e immuno-attivazione T in pazienti coinfetti HIV/HCV sottoposti a farmaci ad azione diretta anti HCV (DAA) Innate immunity and immune activation in HIV/HCV coinfected subjects undergoing DAA
- Impatto dell'eradicazione di HCV nel controllo dell'immunoattivazione residua in pazienti HIV/HCV coinfetti - HCV eradication in HIV/HCV co-infected patients: impact on residual immune-activation.
Immunità mucosale nella donna HIV positiva in terapia antiretrovirale efficace: biomarcatori e correlati clinici Mucosal Immunity in HIV-1 infected women undergoing effective antiretroviral therapy: biomarkers and clinical determinants
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma